ask="1.30"
ask_size="1200"
average_daily_volume="196958"
bid="1.27"
bid_size="2200"
book_value="1.98"
change="+0.11"
change_from_200_day_moving_average="-0.24"
change_from_50_day_moving_average="0.05"
change_from_52_week_high="-4.11"
change_From_52_week_low="0.82"
change_in_percent="+2.80%"
close="4.04"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.28"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.14"
ex_dividend_date="N/A"
float_shares="8580000"
high="4.05"
high_52_weeks="8.15"
last_trade_date="1/31/2017"
last_trade_price="4.04"
last_trade_size="100"
last_trade_time="3:59pm"
low="3.81"
low_52_weeks="3.22"
market_capitalization="75.35M"
moving_average_200_day="4.28"
moving_average_50_day="3.99"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="17.00"
open="3.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-5.62%"
percent_change_from_50_day_moving_average="+1.31%"
percent_change_from_52_week_high="-50.43%"
percent_change_from_52_week_low="+25.47%"
previous_close="3.93"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.99"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="1.69"
stock_exchange="NGM"
symbol="CATB"
volume="939214"
weeks_range_52="3.22 - 8.15"
